Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Titan Pharmaceuticals Inc

TTNP
Current price
4.18 USD +0.066 USD (+1.60%)
Last closed 4.1 USD
ISIN US8883146065
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 684 363 USD
Yield for 12 month -45.29 %
1Y
3Y
5Y
10Y
15Y
TTNP
21.11.2021 - 28.11.2021

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California. Address: 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7 USD

P/E ratio

Dividend Yield

Current Year

+184 000 USD

Last Year

+60 000 USD

Current Quarter

Last Quarter

+81 000 USD

Current Year

+72 000 USD

Last Year

-136 000 USD

Current Quarter

-3 000 USD

Last Quarter

-2 000 USD

Key Figures TTNP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 094 000 USD
Operating Margin TTM -237633.33 %
PE Ratio
Return On Assets TTM -172.63 %
PEG Ratio
Return On Equity TTM -368.99 %
Wall Street Target Price 7 USD
Revenue TTM 3 000 USD
Book Value 4.37 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM -4 365 000 USD
Earnings per share -6.64 USD
Diluted Eps TTM -6.64 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics TTNP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TTNP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 09.01.2024
Dividend Date 01.12.2020

Stock Valuation TTNP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.0433
Price Sales TTM 1220.4717
Enterprise Value EBITDA -0.9169
Price Book MRQ 0.8701

Financials TTNP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TTNP

For 52 weeks

3.57 USD 14.8 USD
50 Day MA 5.19 USD
Shares Short Prior Month 18 660
200 Day MA 6.24 USD
Short Ratio 1.22
Shares Short 16 968
Short Percent 2.29 %